Literature DB >> 34509601

Halocins, natural antimicrobials of Archaea: Exotic or special or both?

Vijay Kumar1, Bijender Singh2, Marco J van Belkum3, Dzung B Diep4, Michael L Chikindas5, Alexey M Ermakov6, Santosh Kumar Tiwari7.   

Abstract

Haloarchaea are adapted to survive under extreme saline conditions by accumulating osmolytes and salts to counteract the high osmotic pressure in their habitats. As a consequence, their proteins have evolved to remain active, or even most active, at very high ionic strength. Halocins are proteinaceous antimicrobial substances that are ribosomally-synthesized by haloarchaea and they provide the producers an advantage in the competition for nutrients and ecological niches. These antimicrobials are stable at high temperature, elevated salt concentrations, and alkaline pH conditions. These properties have endowed them with great potential in diverse biotechnological applications, which involve extreme processing conditions (such as high salt concentrations, high pressure, or high temperatures). They kill target cells by inhibition of Na+/H+ antiporter in the membrane or modification/disruption of the cell membrane leading to cell lysis. In general, the taxonomy of haloarchaea and their typical phenotypic and genotypic characteristics are well studied; however, information regarding their halocins, especially aspects related to genetics, biosynthetic pathways, mechanism of action, and structure-function relationship is very limited. A few studies have demonstrated the potential applications of halocins in the preservation of salted food products and brine-cured hides in leather industries, protecting the myocardium from ischemia and reperfusion injury, as well as from life-threatening diseases such as cardiac arrest and cancers. In recent years, genome mining has been an essential tool to decipher the genetic basis of halocin biosynthesis. Nevertheless, this is likely the tip of the iceberg as genome analyses have revealed many putative halocins in databases waiting for further investigation. Identification and characterization of this source of halocins may lead to antimicrobials for future therapeutics and/or food preservation. Hence, the present review analyzes different aspects of halocins such as biosynthesis, mechanism of action against target cells, and potential biotechnological applications.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antimicrobial peptide; Archaeocin; Bacteriocin; Haloarchaea; Halocin; Mode of action; Therapeutics

Mesh:

Substances:

Year:  2021        PMID: 34509601     DOI: 10.1016/j.biotechadv.2021.107834

Source DB:  PubMed          Journal:  Biotechnol Adv        ISSN: 0734-9750            Impact factor:   14.227


  5 in total

1.  Design of a specific peptide against phenolic glycolipid-1 from Mycobacterium leprae and its implications in leprosy bacilli entry.

Authors:  Nelson Enrique Arenas; Gilles Pieffet; Cristian Rocha-Roa; Martha Inírida Guerrero
Journal:  Mem Inst Oswaldo Cruz       Date:  2022-07-18       Impact factor: 2.747

2.  The Viral Susceptibility of the Haloferax Species.

Authors:  Zaloa Aguirre Sourrouille; Sabine Schwarzer; Sebastian Lequime; Hanna M Oksanen; Tessa E F Quax
Journal:  Viruses       Date:  2022-06-20       Impact factor: 5.818

3.  SPI "sandwich": Combined SUMO-Peptide-Intein expression system and isolation procedure for improved stability and yield of peptides.

Authors:  Tess Lamer; Marco J van Belkum; Anjalee Wijewardane; Sorina Chiorean; Leah A Martin-Visscher; John C Vederas
Journal:  Protein Sci       Date:  2022-05       Impact factor: 6.993

4.  Comparative genomics reveals response of Rhodococcus pyridinivorans B403 to phenol after evolution.

Authors:  Fang Peng; Meng Ye; Yanfang Liu; Jiashu Liu; Ying Lan; Aihu Luo; Tianyi Zhang; Zhengbing Jiang; Huiting Song
Journal:  Appl Microbiol Biotechnol       Date:  2022-03-12       Impact factor: 4.813

5.  Improving the Therapeutic Index of Smp24, a Venom-Derived Antimicrobial Peptide: Increased Activity against Gram-Negative Bacteria.

Authors:  Kirstie M Rawson; Melissa M Lacey; Peter N Strong; Keith Miller
Journal:  Int J Mol Sci       Date:  2022-07-20       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.